FTO and acute myeloid leukemia: Recently, Huang et al. reported two new small molecule inhibitors of FTO, namely, FB23 and FB23-2, directly binding to FTO and specifically inhibiting the activity of m6A demethylase of FTO, finally resulting in the suppression of AML cell proliferation (Huang et al., 2019).